ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Clay M. Burnett
Michael S. Sweeney
Branislav Radovancevic
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burnett, C. M.
Right arrow Articles by Radovancevic, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burnett, C. M.
Right arrow Articles by Radovancevic, B.

Ann Thorac Surg 1993;55:65-71
© 1993 The Society of Thoracic Surgeons

Articles

Improved multiorgan function after prolonged univentricular support

Clay M. Burnett, MDa,b, J. Michael Duncan, MDa,b, O.H. Frazier, MD*,a,b, Michael S. Sweeney, MDa,b, J. David Vega, MDa,b, Branislav Radovancevic, MDa,b

a Transplant Service, Texas Heart Institute/St. Luke's Episcopal Hospital, Houston, Texas USA
b University of Texas Medical School at Houston, Houston, Texas USA

* Address reprint requests to Dr Frazier, Texas Heart Institute, PO Box 20345, Houston, TX 77225-0345.

Eleven cardiac transplant candidates (all male; mean age, 43.3 years) with multiorgan (hepatic, pulmonary, and/or renal) dysfunction were sustained for prolonged periods (>30 days) with the HeartMate (Thermo Cardiosystems, Inc, Woburn, MA) left ventricular assist device. We evaluated the effect of extended support on end-organ recovery and on the ultimate outcome of cardiac transplantation. In addition to cardiac failure, 9 patients had hepatic dysfunction, 8 had pulmonary dysfunction, and 6 had renal dysfunction (4 of whom required hemodialysis before left ventricular assist device support). Mean duration of support was 115 days (range, 31 to 233 days). All patients underwent successful transplantation; 10 of these patients survived a mean of 24 months. One patient, who had required hemodialysis and ventilatory support during and after support, experienced progressive multiorgan failure and died 7 weeks after transplantation. Two late deaths after transplantation were unrelated to the device. Overall, patients experienced improvement in cardiac functional class status, and most participated in cardiac rehabilitation programs before transplantation. During left ventricular assist device support, hepatic function returned to normal in 8 patients, pulmonary function recovered in 7, and renal function returned to normal in 4. One patient who required hemodialysis underwent renal transplantation after cardiac transplantation and had complete recovery of renal function. In the current era of donor shortages, gravely ill patients can benefit from a strategy of prolonged left ventricular assist device support. This strategy has proved safe, has allowed for reversal of multiorgan dysfunction, and has produced healthier transplant candidates.




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
E. A. Genovese, M. A. Dew, J. J. Teuteberg, M. A. Simon, J. Kay, M. P. Siegenthaler, J. K. Bhama, C. A. Bermudez, K. L. Lockard, S. Winowich, et al.
Incidence and Patterns of Adverse Event Onset During the First 60 Days After Ventricular Assist Device Implantation
Ann. Thorac. Surg., October 1, 2009; 88(4): 1162 - 1170.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
U. N. Khot, M. Mishra, M. H. Yamani, N. G. Smedira, E. Paganini, M. Yeager, T. Buda, P. M. McCarthy, J. B. Young, and R. C. Starling
Severe renal dysfunction complicating cardiogenic shock is not a contraindication to mechanical support as a bridge to cardiac transplantation
J. Am. Coll. Cardiol., February 5, 2003; 41(3): 381 - 385.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
O. H. Frazier, E. A. Rose, M. C. Oz, W. Dembitsky, P. McCarthy, B. Radovancevic, V. L. Poirier, and K. A. Dasse
Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation
J. Thorac. Cardiovasc. Surg., December 1, 2001; 122(6): 1186 - 1195.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
O.H. Frazier, T. J. Myers, R. K. Jarvik, S. Westaby, D. W. Pigott, I. D. Gregoric, T. Khan, D. W. Tamez, J. L. Conger, and M. P. Macris
Research and development of an implantable, axial-flow left ventricular assist device: the Jarvik 2000 Heart
Ann. Thorac. Surg., March 1, 2001; 71(2007): S125 - S132.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
O.H. Frazier and T. J. Myers
Left ventricular assist system as a bridge to myocardial recovery
Ann. Thorac. Surg., August 1, 1999; 68(2): 734 - 741.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
W. E. Pae Jr, J. M. Anderson, E. H. Blackstone, H. S. Boroevetz, A. Ciarkowski, J. G. Copeland III, M. R. Costanzo-Nordin, K. Daase, M. A. Dew, M. J. Domanski, et al.
Bethesda conference: conference for the design of clinical trials to study circulatory support devices for chronic heart failure
Ann. Thorac. Surg., October 1, 1998; 66(4): 1452 - 1465.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
N. Moazami, M. Argenziano, T. Kohomoto, S. Yazdani, E. A. Rose, D. Burkhoff, and M. C. Oz
Inflow Valve Regurgitation During Left Ventricular Assist Device Support May Interfere With Reverse Ventricular Remodeling
Ann. Thorac. Surg., March 1, 1998; 65(3): 628 - 631.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
B. E. Jaski, J. Kim, R. S. Maly, K. R. Branch, R. Adamson, L. K. Favrot, S. C. Smith Jr, and W. P. Dembitsky
Effects of Exercise During Long-term Support With a Left Ventricular Assist Device : Results of the Experience With Left Ventricular Assist Device With Exercise (EVADE) Pilot Trial
Circulation, May 20, 1997; 95(10): 2401 - 2406.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
P. M. McCarthy, S. K. Schmitt, R. L. Vargo, S. Gordon, T. F. Keys, and R. E. Hobbs
Implantable LVAD Infections: Implications for Permanent Use of the Device
Ann. Thorac. Surg., January 1, 1996; 61(1): 359 - 365.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
P. M. McCarthy, S. Nakatani, R. Vargo, K. Kottke-Marchant, H. Harasaki, K. B. James, R. M. Savage, and J. D. Thomas
Structural and left ventricular histologic changes after implantable LVAD insertion
Ann. Thorac. Surg., March 1, 1995; 59(3): 609 - 613.
[Abstract] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
P. M. McCarthy, R. M. Savage, C. D. Fraser, R. Vargo, K. B. James, M. Goormastic, R. E. Hobbs, and S. b. D. M. Cosgrove
Hemodynamic and physiologic changes during support with an implantable left ventricular assist device
J. Thorac. Cardiovasc. Surg., March 1, 1995; 109(3): 409 - 418.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
P. M. McCarthy
HeartMate implantable left ventricular assist device: Bridge to transplantation and future applications
Ann. Thorac. Surg., February 1, 1995; 59(suppl_1): S46 - S51.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1993 by The Society of Thoracic Surgeons.